Corrigendum to audited financial statement results for the quarter and year ended on 31.03.2026 is attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mercury Laboratories has filed a corrigendum to its audited financial results for FY2026, correcting two errors in the originally filed documents. The first correction addresses a typographical error in the Balance Sheet under current liabilities. The second correction relates to the Cash Flow Statement where changes in 'Other Non-Current Liabilities' under financing activities were inadvertently omitted, causing the total net change in cash and cash equivalents to be understated. FY2026 revenue from operations was Rs 7,789.18 lakh (vs Rs 7,616.99 lakh in FY2025), profit before tax was Rs 483.40 lakh (vs Rs 314.49 lakh), and net profit after tax was Rs 345.46 lakh (vs Rs 306.25 lakh). The auditors issued an unmodified (clean) opinion. The company also declared a dividend of 35% (Rs 3.50 per share) and took an exceptional item provision related to new labour codes.
The corrections are administrative in nature and relate to cash flow classification rather than profit changes. The company remains profitable with a clean audit opinion, and the filing should have minimal negative impact on the stock. The understated cash position from the financing activity omission may have been slightly favourable to previously reported cash flows.